^Raghuvanshi R, Bharate SB (January 2022). "Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections". Journal of Medicinal Chemistry. 65 (2): 893–921.
doi:
10.1021/acs.jmedchem.0c01467.
PMID33539089.
^Zalewski A, Szepietowski JC (April 2023). "Topical and systemic JAK inhibitors in hand eczema - a narrative review". Expert Review of Clinical Immunology. 19 (4): 365–373.
doi:
10.1080/1744666X.2023.2174526.
PMID36708316.
^Raghuvanshi R, Bharate SB (January 2022). "Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections". Journal of Medicinal Chemistry. 65 (2): 893–921.
doi:
10.1021/acs.jmedchem.0c01467.
PMID33539089.
^Zalewski A, Szepietowski JC (April 2023). "Topical and systemic JAK inhibitors in hand eczema - a narrative review". Expert Review of Clinical Immunology. 19 (4): 365–373.
doi:
10.1080/1744666X.2023.2174526.
PMID36708316.